茚满
茚满结构式
|
常用名 | 茚满 | 英文名 | Indane |
|---|---|---|---|---|
| CAS号 | 496-11-7 | 分子量 | 118.176 | |
| 密度 | 1.0±0.1 g/cm3 | 沸点 | 176.5±0.0 °C at 760 mmHg | |
| 分子式 | C9H10 | 熔点 | −51 °C(lit.) | |
| MSDS | 中文版 美版 | 闪点 | 50.0±0.0 °C | |
| 符号 |
GHS02, GHS08 |
信号词 | Danger |
|
Bicyclic naphthenic acids in oil sands process water: identification by comprehensive multidimensional gas chromatography-mass spectrometry.
J. Chromatogr. A. 1378 , 74-87, (2015) Although bicyclic acids have been reported to be the major naphthenic acids in oil sands process-affected water (OSPW) and a well-accepted screening assay indicated that some bicyclics were the most acutely toxic acids tested, none have yet been identified. H... |
|
|
Desaturation, dioxygenation, and monooxygenation reactions catalyzed by naphthalene dioxygenase from Pseudomonas sp. strain 9816-4.
J. Bacteriol. 177(10) , 2615-21, (1995) The stereospecific oxidation of indan and indene was examined with mutant and recombinant strains expressing naphthalene dioxygenase of Pseudomonas sp. strain 9816-4. Pseudomonas sp. strain 9816/11 and Escherichia coli JM109(DE3)[pDTG141] oxidized indan to (+... |
|
|
Predictive three-dimensional quantitative structure-activity relationship of cytochrome P450 1A2 inhibitors.
J. Med. Chem. 48 , 3808-15, (2005) The purpose of this study was to determine the cytochrome P450 1A2 (CYP1A2) inhibition potencies of structurally diverse compounds to create a comprehensive three-dimensional quantitative structure-activity relationship (3D-QSAR) model of CYP1A2 inhibitors an... |
|
|
Aromatic hydroxylation of indan by o-xylene-degrading Rhodococcus sp. strain DK17.
Appl. Environ. Microbiol. 76(1) , 375-7, (2010) The metabolically versatile Rhodococcus sp. strain DK17 utilizes indan as a growth substrate via the o-xylene pathway. Metabolite and reverse transcription-PCR analyses indicate that o-xylene dioxygenase hydroxylates indan at the 4,5 position of the aromatic ... |
|
|
Selective inhibition of carboxylesterases by isatins, indole-2,3-diones.
J. Med. Chem. 50 , 1876-85, (2007) Carboxylesterases (CE) are ubiquitous enzymes thought to be responsible for the metabolism and detoxification of xenobiotics. Numerous clinically used drugs including Demerol, lidocaine, capecitabine, and CPT-11 are hydrolyzed by these enzymes. Hence, the ide... |
|
|
Simultaneous determination of ethylbenzene, indan, indene and acenaphthene in air by capillary gas chromatography.
J. Chromatogr. A. 891(2) , 361-5, (2000) An attempt was made to establish a method for the simultaneous determination of ethylbenzene, indan, indene and acenaphthene by capillary gas chromatography with flame ionization detection. The air was sampled on charcoal tubes and extracted with carbon disul... |
|
|
(1S)-1-Phenylethanaminium 4-{[(1S,2S)-1-hydroxy-2,3-dihydro-1H,1'H-[2,2'-biinden]-2-yl]methyl}benzoate.
Acta Crystallogr. C 68(Pt 8) , o323-6, (2012) The title molecular salt, C(8)H(12)N(+)·C(26)H(21)O(3)(-), contains a dimeric indane pharmacophore that demonstrates potent anti-inflammatory activity. The indane group of the anion exhibits some disorder about the α-C atom, which appears common to many struc... |
|
|
Novel 5-dimethylamino-1- and 2-indanyl uracil derivatives.
J. Org. Chem. 71(18) , 7053-6, (2006) 5-Dimethylamino-1-aminoindan undergoes thermal decomposition and reacts with 6-chlorouracil to give 5-indanyl-6-chlorouracil derivative 9. The formation of 9 may be rationalized by a putative mechanism based on the intermediacy of the imminium methide species... |
|
|
Kinetic resolutions of indan derivatives using bacteria.
Biosci. Biotechnol. Biochem. 66(2) , 464-6, (2002) Racemic indan derivatives have been resolved by the hydrolysis of amide bonds using Corynebacterium ammoniagenes IFO12612 to produce (S)-amine and (R)-amides. In the kinetic resolution of 1 (N-12-(6-methoxy-indan-1-yl)ethyl]acetamide), it was possible to run ... |
|
|
Discovery of a series of indan carboxylic acid glycogen phosphorylase inhibitors.
Bioorg. Med. Chem. Lett. 20(12) , 3511-4, (2010) A series of carboxylic acid glycogen phosphorylase inhibitors, which have potential as oral antidiabetic agents, is described. Defining and applying simple physicochemical design criteria was used to assess the opportunity and to focus synthetic efforts on co... |